hotspot -WSS

hotspot

author：explore 2025-10-01 00:47:38 - browse：95

portrait of Jennifer Adair -- coverage from STAT — Jennifer Adair develops scalable, low cost gene therapies at the Fred Hutchinson Cancer Center and helped found the Global Gene Therapy Initiative. Fred Hutch News Service

BALTIMORE — Gene and cell therapies have transformed a handful of devastating disorders in the U.S. and Europe, with more treatments on the way. But those technologies have largely failed to reach most of the world.

These lags are ubiquitous in the current drug development system, where new therapies are approved in wealthy countries and then slowly leak out to low- and middle-income countries, many years later. In the case of gene therapy, that means countries most affected by a disease such as sickle cell may wait decades to access a curative therapy.

For the last few years, a handful of researchers in the U.S. and around the world have tried to find ways of ensuring global access to these technologies. In 2020, they formed the Global Gene Therapy Initiative, with an initial goal of setting up a gene therapy clinical trial for a hemoglobinopathy — such as a disease like sickle cell or beta thalassemia — or HIV in two different low- and middle-income countries by 2024.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Intercept Pharmaceuticals sells itself for less than $1 billion

leisure time

focus

WSS

‘The Bear’ and hospitality in hospitals

Discs beat pads, tampons for heavy menstrual flow, new study shows

The painfully weak evidence on taking collagen to treat arthritis

Ohioans vote in high

Researchers use wearables data and AI to predict preterm birth risk

Sage's campaign to raise awareness of postpartum depression hits a nerve

knowledge

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Dobbs anniversary: the lost opportunity of abortion as health care

Hospitals use virtual reality to design more inclusive rooms for kids

Apple is now the first public company to be valued at $3 trillion

Sage's campaign to raise awareness of postpartum depression hits a nerve

Affirmative action in medical school literally saved lives

Discs beat pads, tampons for heavy menstrual flow, new study shows

Walensky prepares to leave CDC — and Congress — behind

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

The cancer drug shortage isn’t new — and neither are the solutions

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

focus

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

WHO recommends dropping component of many flu vaccines

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Covid vaccines: Private market messier than government rollout

leisure time

leisure time

focus

explore